|
DPH2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.491500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.091200E-01 |
| Normal-vs-Stage2 |
4.680000E-01 |
| Normal-vs-Stage3 |
6.198800E-01 |
| Normal-vs-Stage4 |
2.199600E-01 |
| Stage1-vs-Stage2 |
9.504400E-01 |
| Stage1-vs-Stage3 |
7.908600E-01 |
| Stage1-vs-Stage4 |
1.896390E-01 |
| Stage2-vs-Stage3 |
7.918600E-01 |
| Stage2-vs-Stage4 |
3.252800E-01 |
| Stage3-vs-Stage4 |
3.152600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.724000E-02 |
| Normal-vs-AfricanAmerican |
1.622020E-01 |
| Normal-vs-Asian |
5.951600E-01 |
| Caucasian-vs-AfricanAmerican |
9.090400E-01 |
| Caucasian-vs-Asian |
3.733600E-01 |
| AfricanAmerican-vs-Asian |
3.098000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.196590E-01 |
| Normal-vs-Female |
3.889900E-02 |
| Male-vs-Female |
3.324000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.615000E-01 |
| Normal-vs-Extreme_Weight |
6.163400E-01 |
| Normal-vs-Obese |
5.205400E-01 |
| Normal-vs-Extreme_Obese |
1.893040E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.742800E-01 |
| Normal_Weight-vs-Obese |
7.281600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.521200E-01 |
| Extreme_Weight-vs-Obese |
8.182200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.105810E-01 |
| Obese-vs-Extreme_Obese |
2.141000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.606170E-02 |
| Normal-vs-Age(41-60Yrs) |
4.794400E-02 |
| Normal-vs-Age(61-80Yrs) |
1.482250E-01 |
| Normal-vs-Age(81-100Yrs) |
3.477200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.415800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.813800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.387000E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.703400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.809900E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.695750E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.072200E-02 |
| Normal-VS-Type2 PRCC |
7.004400E-01 |
| Normal-VS-KIRP CIMP |
5.081200E-01 |
| Normal-VS-Unclassified PRCC |
3.461800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.442200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.862200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.203800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.390000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.330640E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.256400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.307600E-01 |
| Normal-vs-N1 |
2.321000E-01 |
| Normal-vs-N2 |
7.220800E-01 |
| N0-vs-N1 |
1.719170E-01 |
| N0-vs-N2 |
6.819800E-01 |
| N1-vs-N2 |
9.377800E-01 |
|
|
